Collaboration - September 29, 2026
AstraZeneca takes USD 2 billion stake in Summit
The company is investing USD 2 billion in Summit Therapeutics and launching a clinical collaboration that will combine Summit's PD-1/VEGF bispecific antibody ivonescimab with AstraZeneca's antibody drug conjugates (ADCs), starting in gastrointestinal cancers.
Collaboration - September 16, 2026
Swedish healthcare delegation visits Kyiv as Russian attacks on civilians intensify
A Swedish healthcare delegation traveled to Kyiv on September 2–4 to strengthen cooperation on rebuilding Ukraine's healthcare system, timed to one of the most difficult periods for the city in months.
Collaboration - September 15, 2026
The Novo Nordisk Foundation and NordForsk sign framework agreement
The Novo Nordisk Foundation (NNF) and NordForsk have signed a framework agreement to fund Nordic research co-operation over the period 2026–2030.
Collaboration - September 14, 2026
RaySearch and Accuray expand collaboration on online adaptive radiotherapy
RaySearch Laboratories and US-based Accuray have entered a definitive agreement to expand their collaboration on online adaptive radiation therapy, with Accuray committing to purchase RayStation software licences worth USD 8 million.
Collaboration - September 8, 2026
HeartBeat.bio and Cubase Bio partner to advance 3D spatial transcriptomics
Vienna-based HeartBeat.bio and Stockholm-based Cubase Bio have been awarded roughly EUR 1 million in Eurostars funding to develop a 3D spatial profiling method for studying myocardial fibrosis and heart failure, combining human cardiac organoids with true 3D spatial transcriptomics technology.
Collaboration - September 8, 2026
Klaria and RTHS partner to enable earlier detection and treatment of migraine
Klaria has entered a collaboration agreement with RTHS to combine RTHS's sensor-based measurements of blood flow dynamics with Klaria's approved migraine treatment, aiming to detect migraine attacks before symptoms set in.